Hybrid coronary revascularization in multivessel coronary artery disease: a systematic review

Hybrid coronary revascularization (HCR) for multivessel coronary artery disease (CAD) integrates coronary artery bypass grafting (CABG) and percutaneous intervention in a planned revascularization strategy. This systematic review summarizes the state of this art of this technique. Major databases se...

Full description

Saved in:
Bibliographic Details
Published in:Future cardiology 2022-03, Vol.18 (3), p.219-234
Main Authors: Nenna, Antonio, Nappi, Francesco, Spadaccio, Cristiano, Greco, Salvatore Matteo, Pilato, Michele, Stilo, Francesco, Montelione, Nunzio, Catanese, Vincenzo, Lusini, Mario, Spinelli, Francesco, Chello, Massimo
Format: Article
Language:English
Subjects:
coronary artery bypass grafting
hybrid coronary revascularization
myocardial revascularization
percutaneous coronary intervention
systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hybrid coronary revascularization (HCR) for multivessel coronary artery disease (CAD) integrates coronary artery bypass grafting (CABG) and percutaneous intervention in a planned revascularization strategy. This systematic review summarizes the state of this art of this technique. Major databases searched until October 2021. The available literature on HCR includes three randomized trials, ten meta-analysis and 27 retrospective studies. The greatest benefits are observed in patients with low-to-intermediate risk and less complex coronary anatomy; highly complex disease and the presence of risk factors favored conventional CABG in terms of adverse events and survival. HCR is an interesting approach for multivessel CAD but should not be considered a ‘one-size-fits-all’ procedure. Further studies will specify the subset of patients likely to benefit most from this hybrid approach.
ISSN:1479-6678
1744-8298
DOI:10.2217/fca-2020-0244